$4.18
0.08[1.95%]
At close: May 3
$4.18
0[0.00%]
After Hours: 7:52PM EDT
Fate Therapeutics
(NASDAQ:FATE)Fate Therapeutics Stock (NASDAQ:FATE), Earnings Estimates, EPS, and Revenue
Fate Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 17
EPS Estimate
$-0.490
Quarterly Revenue Estimate
$1.1M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$63.5M
Analyze the earnings history of Fate Therapeutics using advanced sorting and filters.
No data available to display
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|
FAQ
When is Fate Therapeutics (NASDAQ:FATE) reporting earnings?
Fate Therapeutics (FATE) is scheduled to report earnings on May 17, 2024. The last reported earnings were for reported on February 26, 2024 for Q4.
What were the latest earnings per share (EPS) for Fate Therapeutics (NASDAQ:FATE)?
The Actual EPS was $-0.45, which beat the estimate of $-0.52.
What were Fate Therapeutics’s (NASDAQ:FATE) revenues?
The Actual Revenue was $1.7M, which beat the estimate of $1.6M.
Browse earnings estimates, EPS, and revenue on all stocks.